Oncology

Focus:Oncology
Type:database (supplied by e-mail as setup.exe file)
No. of deals: 319
No. of companies: 242
Years covered: 1996 – 2011
Price: € 975 ex VAT (if applicable)
System requirements: Windows 2000/Windows XP/Windows Vista/7
Publisher:PharmaPlus Consultancy B.V.

Are you about to enter deal negotiations for your Oncology therapeutic?


Use PharmaDeal Financials Oncology to benchmark your next Oncology deal


PharmaDeal Financials Oncology

  • Deal specifics on more than 320 oncology deals
  • Deal making trends since 1996
  • Worldwide licenses and specific territory licenses including Asia and Japan
  • All indications and compound classes including antibodies, vaccines and kinase inhibitors
  • 45% early stage deals
  • 24% antibody-related deals
  • Phase III regulatory milestones from USD 2 to USD 60 million
  • Royalties up to 39%
  • Equity from USD 0.5 million to USD 1 billion

Each deal entry is categorized and searchable by licensor, licensee, indication, compound details, compound name, development stage (research-filed), geographical territory, potential deal size, upfront, total milestones-regulatory milestones-sales milestones payments, profit sharing, royalties on sales, research funding, equity and by year of deal establishment or any combination thereof.

Indications (selection)

Advanced polycythema vera, bile duct tumors, bladder cancer, bone metastases, brain metastases, brain tumors, breast cancer, cervical cancer, colon cancer, colorectal cancer, esophageal cancer, gastric cancer, glioblastoma, glioma, head & neck cancer, hepatocellular carcinoma, leukemia’s, liver cancer, lung cancer, lymphoma’s (Hodgkin’s lymphoma, non-Hodgkin’s lymphoma), melanoma, mesothelioma, metastasis, multiple myeloma, nasopharyngeal cancer, oesophageal cancer, ovarian cancer, pancreatic cancer, prostate cancer, renal cell carcinoma, sarcoma, solid tumors, thyroid cancer, uterin cancer

Selected compound keywords

Adnectins, Akt inhibitors, angiogenesis inhibitors, alkylating agents, angiogenesis inhibitors, anthracyclines, antibodies, anti-androgens, antisense, aptamers, apoptosis inhibitors, campothecins, cell cycle inhibitors, Chk-1 modulators, cytokines, FLT3-inhibitors, fusion proteins, heat shock protein inhibitors, HDAC inhibitors, hedgehog sigaling pathway inhibitors, histone methyltransferase inhibitors, hormones, immunotherapy, JAK-inhibitors, kinase inhibitors, MEK-inhibitors, mTOR inhibitors, nanobodies, nucleoside analogues, pepcudins, PI3K inhibitors, platinum compounds, prodrugs, proteaseome inhibitors, protein interaction inhibitors, RNAi, stapled paptides, stem cells, tarmogens, taxanes, topoisomerase inhibitors, TLR-agonists, tumor activated prodrugs, tyrosine kinase inhibitors, vaccines, vascular disrupting agents, VEGF inhibitors, vinca alkaloids

Companies included in database

3M Company, Abbott Laboratories, Ablynx, Active Biotech, Adherex Technologies, Advancell, Aegera Therapeutics, Aeterna Zentaris, Agennix (GPC Biotech), Agensys, Agios Pharmaceuticals, Aileron Therapeutics, Akela Pharma (StressGen Biotechnologies Corporation), Alfacell Corporation, Algeta, Allergan, Allos Therapeutics, Alnylam Pharmaceuticals, Ambit Biosciences Corporation, Ambrilia Biopharma, American Biosciences, Amgen (Abgenix, Tularik), Amplimmune, Anchor Therapeutics, Anges MG, Angiochem, Anthra Pharmaceuticals, Antisoma, Aphton Corporation, Archemix Corporation, Ardea Biosciences, Ariad Pharmaceuticals, Arqule, Array Biopharma, Arrowhead Research Corporation (Calando Pharmaceuticals), Ascenta Theapeutics, Astellas Pharma (UroGenesys), Astex Therapeutics (SuperGen), AstraZeneca (Cambridge Antibody Technology, MedImmune, Zeneca), Aurigene Discovery Technologies, Avant Immunotherapeutics (Celldex Therapeutics), Avantogen Oncology (Resistys), AVEO Pharmaceuticals (GenPath Pharmaceuticals), AVI Biopharma, Avila Therapeutics, Bayer Schering Pharma (Bayer, Schering AG), Beartown Pharma, BioCryst Pharmaceuticals, Biogen Idec (Biogen, Idec Pharmaceuticals), Biohybrid, Bioinvent International, Bioniche Life Sciences, Biota Holdings (BiotaTechnology), Biovector Therapeutics, BL&H Co., Boehringer Ingelheim Pharma, Boston Biomedical, Bristol-Myers Squibb (Adnexus Therapeutics, Kosan Biosciences, Medarex), BTG (Protherics), Catalyst Biosciences, Cel-Sci Corporation, Celera Corporation (Celera Genomics), Celgene Corporation (Pharmion Corporation), Cell Genesys, Cell Therapeutics, CellCentric, Celldex Therapeutics (Curagen), Celsion Corporation, Celtic Pharma (Xenova), Cephalon, Cerulean Pharma, Cerus Corporation, CGI Pharmaceuticals, Chroma Therapeutics, Clavis Pharma, Clovis Oncology, CombinatoRx, Cyclacel, Cytokinetics, Daiichi Sankyo, Dainippon Sumitomo Pharma Co. (Dainippon Pharmaceutical Co.), Danisco (Genencor), Debiopharm, Deciphera Pharmaceuticals, Dicerna Pharmaceuticals, Dompé Farmaceutici, Dyax Corporation, Eisai Co. (MGI Pharma), Eli Lilly & Company (Applied Molecular Evolution/Ixsys, ImClone Systems, SGX Pharmaceuticals), Emergent BioSolutions (Trubion Pharmaceuticals), Endo Pharmaceuticals, Epicept Corporation (Maxim Pharmaceuticals), Epizyme, Eusa Pharma, Exelixis, Facet Biotech Corporation (PDL Biopharma, Protein Design Labs/Eos Biotechnology), Faulding Pharmaceuticals, Five Prime Therapeutics, Forest Laboratories (Clinical Data (Avalon Pharmaceuticals)), Galapagos (Biofocus), Galaxy Biotech, Genmab, Genta, Geron Corporation, GlaxoSmithKline (Corixa, Coulter Pharmaceuticals, Domantis, GlaxoWellcome, Praecis Pharmaceutials, SmithKline Beecham), GlobeImmune, Guilford Pharmaceuticals, Hana Biosciences, Handok Pharmaceutical Co., Hanmi Pharmaceutials, Helsinn Healthcare, Hikma Pharmaceuticals, Human Genome Sciences, Idera Pharmaceuticals, Immuno-Biological Laboratories, ImmunoGen, Immunomedics, Incyte Corporation, Inex Pharmaceutical Corporation, Infinity Pharmaceuticals, Inflazyme Pharmaceuticals (GlycoDesign), Innate Pharma, Innogene Kalbiotech, Innovive Pharmaceuticals, Inotek Pharmaceutials, Ipsen Pharma (Beaufour Ipsen), Isis Pharmaceuticals, ItherX Pharmaceuticals (Immusol), Japan Tobacco, Jennerex BioTherapeutics, Johnson & Johnson (Centocor, Janssen Biotech, Janssen Pharmaceutica, Ortho-McNeil), Karo Bio, Keryx Biopharmaceuticals (Access Oncology), Kinex Pharmaceuticals, Kotinos Pharmaceuticals, Kowa Company, KS Biomedix, Kyowa Hakko Kirin Co.(Kirin Brewery, Kyowa Hakko), Lpath, MacroGenics, Marina Biotech, Medigen Biotechnology Corporation, MediGene, Medivation, Merck & Co.(Schering-Plough), Merck Serono (Merck KGaA, Serono), Merrimack Pharmaceuticals, Mersana Therapeutics, Merus Biopharmaceuticals, Mesoblast, Metamark Genetics, MethylGene, Micromet (CancerVax), MorphoSys, Mundipharma, Myriad Genetics, NanoCarrier Co., NeoPharm, Nerviano Medical Sciences, Neurocrine Biosciences, Nippon Kayaku Co., Nippon Shinyaku, Novartis (Chiron), Novocell (BresaGen), Nycomed, Oncolys Biopharma, OncoGenex Pharmaceuticals, Oncolys Biopharma, Oncomed Pharmaceuticals, Oncoscience, Oncothyreon (Biomira), Ono Pharmaceutical Co., Onyx Pharmaceuticals, Orient Europharma, OSI Pharmaceuticals, Oxford BioMedica, Oxford Biotherapeutics, Paladin Labs (Virexx Medical Corporation/Altarex Corporation), Peplin Biotech, Peregrine Pharmaceuticals (Techniclone), Pfizer (Coley Pharmaceuticals, G.P. Searle & Co, Idun Pharmaceuticals, King Pharmaceuticals, Pharmacia & Upjohn, Pharmacia Corporation, PowderJect Pharmaceuticals, Sugen, Wyeth), Pharmacyclics, PharmaEngine, Pharminox, Pierre Fabre, Plexxikon, Poniard Pharmaceuticals (NeoRx Corporation), Prescient NeuroPharma, Priaxon, Protox Therapeutics, Purdue Pharma, QLT (Atrix Laboratories), Quanticel Pharmaceuticals, Regeneron Pharmaceuticals, Rexahn Pharmaceuticals, Rigel Pharmaceuticals, Roche (Arius Research, Chugai Pharmaceutical Co., Genentech, PIramed), S* Bio, Sanofi (Aventis Pharma, Genzyme Corporation (Anormed, Ilex Oncology), Hoechst Marion Roussel, Pasteur Mérieux Connaught, Rhône-Poulenc Rorer, Sanofi-Aventis, Sanofi-Pasteur, Sanofi-Synthélabo, Synthélabo), SciClone Pharmaceuticals, Scil Technology (Scil Biomedicals), Seattle Genetics, Seikagaku Corporation, Servier, Shire (Biochem Pharma), SkyePharma (Depotech Corporation), Sosei, Spectrum Pharmaceuticals (NeoTherapeutics), Sunesis Pharmaceuticals, Synta Pharmaceuticals, Taiho Pharmaceutical, Takeda Pharmaceutical Company (IDM Pharma/Epimmune, Millennium Pharmaceuticals/LeukoSite), Tapestry Pharmaceuticals (Napro Biotherapeutics), TenX Biopharma, Teva Pharmaceutical Industries, Thallion Pharmaceuticals (Caprion Pharmaceuticals), Theraclone Sciences, Therion Biologics, TromboGenics, TMRC Co., TopoTarget, Tracon Pharmaceuticals, Tragara Pharmaceuticals, Trancept Pharmaceuticals (Novacea), Transgène, UCB Pharma (Celltech/Medeva), UroGene, Vernalis (British Biotech, Pintex Pharmaceuticals), Vertex Pharmaceuticals, Vical, Virax Holdings, Wellstat Therapeutics Corporaton, Xencor, Xoma, Yakult Honsha Co., YM Biosciences, Zalicus (CombinatoRx), Zambon Group, Zymeworks